Context Positron emission tomography (PET) of 68 Ga-labelled prostate-specific membrane
antigen (68 Ga-PSMA) is an emerging imaging modality introduced to assess the burden of …

Abstract In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee
began the process of a complete update of recommendations for early prostate cancer …

Prostate cancer is a significant public health burden and a major cause of morbidity and
mortality among men worldwide. Analyzing geographic patterns and temporal trends may …

Early detection represents one of the most promising approaches to reducing the growing
cancer burden. It already has a key role in the management of cervical and breast cancer …

Background Any form of screening aims to reduce disease‐specific and overall mortality,
and to improve a person's future quality of life. Screening for prostate cancer has generated …

Background: Screening for prostate cancer advances the time of diagnosis (lead time) and
detects cancers that would not have been diagnosed in the absence of screening …

Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

The major goal for prostate cancer imaging in the next decade is more accurate disease
characterization through the synthesis of anatomic, functional, and molecular imaging …

Abstract Each year the American Cancer Society publishes a summary of existing
recommendations for early cancer detection, including updates, and/or emerging issues that …

Prostate cancer has emerged as the most frequent cancer amongst men in Europe, with
incidence increasing rapidly over the past two decades. Incidence has been uniformly …